@inproceedings{inproceedings, title  = {{CONFIRM: A phase III randomized trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2018}},

 month = {{5}},

 author = {{Fennell DA and Kirkpatrick EV and Cozens K and Danson S and Hanna GG and Lester JF and Lord J and Nye M and Ottensmeier CHH and Szlosarek PW and Steele NL et al}},

 doi = {{10.1200/jco.2018.36.15_suppl.tps8586}},

 volume = {{36}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{TPS8586-TPS8586}},

 note = {{Accessed on 2024/12/26}}}